REGENERON PHARMACEUTICALS, INC. Non-operating Income/Expense 2008-2026 | REGN
Beta
What is REGENERON PHARMACEUTICALS, INC.'s current non-operating income/expense?
REGENERON PHARMACEUTICALS, INC. (REGN) annual non-operating income/expense for 2025 was $1.70B, a 100.92% increase from 2024. REGENERON PHARMACEUTICALS, INC. non-operating income/expense for the quarter ending March 31, 2026 was $188.3M.
What was REGENERON PHARMACEUTICALS, INC.'s non-operating income/expense in 2024?
REGENERON PHARMACEUTICALS, INC. annual non-operating income/expense for 2024 was $844.4M, a 274.96% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s non-operating income/expense in 2023?
REGENERON PHARMACEUTICALS, INC. annual non-operating income/expense for 2023 was $225.2M, a 25.60% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year non-operating income/expense CAGR?
REGENERON PHARMACEUTICALS, INC. non-operating income/expense grew at a compound annual growth rate (CAGR) of 42.31% from FY2020 to FY2025, going from $290.7M to $1.70B over 5 years.
Non-operating Income/Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+42.3%
FY2020
$290.7M
→
FY2025
$1.70B
080910111213141516171819202122232425
5 years selected
Non-operating Income/Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.70B | +100.9% | 10-K |
| FY2024 | $844.4M | +275.0% | 10-K |
| FY2023 | $225.2M | +25.6% | 10-K |
| FY2022 | $179.3M | -58.9% | 10-K |
| FY2021 | $436.3M | +50.1% | 10-K |
| FY2020 | $290.7M | +16.5% | 10-K |
| FY2019 | $249.5M | +427.5% | 10-K |
| FY2018 | $47.3M | +97.1% | 10-K |
| FY2017 | $24.0M | +281.0% | 10-K |
| FY2016 | $6.3M | +123.5% | 10-K |
| FY2015 | $-26.8M | +57.2% | 10-K |
| FY2014 | $-62.7M | -34.3% | 10-K |
| FY2013 | $-46.7M | -7.8% | 10-K |
| FY2012 | $-43.3M | -144.1% | 10-K |
| FY2011 | $-17.7M | -153.5% | 10-K |
| FY2010 | $-7.0M | -425.2% | 10-K |
| FY2009 | $2.2M | -77.3% | 10-K |
| FY2008 | $9.5M | - | 10-K |
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →